Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
1028.8000 2.80 (0.27%)
NSE Jun 12, 2025 15:31 PM
Volume: 208.9K
High volume today

logo
Alivus Life Sciences Ltd.
22 Jul 2023
1028.80
0.27%
buy
by BOB Capital Markets Ltd.
Target: 620
BOB Capital Markets Ltd.
Strong Q1 with EBITDA/PAT beat of 10%/6% despite slight miss on revenue
 
Alivus Life Sciences.. has an average target of 1152.00 from 2 brokers.
More from Alivus Life Sciences Ltd.
Recommended
Market closes lower, SG Mart bags orders worth Rs 266 crore for solar structures
Trendlyne Marketwatch | 12 Jun 2025, 04:08PM
Valuations in some sectors are too hot | Screener: Rising stocks with PE below long term averages
The Baseline | 11 Jun 2025, 10:07PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021